Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

Recruiting N/A Interventional Study
Anxiety Mood Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
5 – 14
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
156 (estimated)
Sponsor
Stanford University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosed with a mood and/or anxiety disorder * Have proficiency to participate in psychotherapy in English * Scheduled to begin therapy at one of the study sites * RCADS score \> 65 Exclusion Criteria: \- Comorbid diagnosis of intellectual disability, autism spectrum disord…
Contacts

Jesse A Barrera, BA

6193792399

barreraj@stanford.edu

CONTACT

David S Hong, MD

(650) 723-5511

dshong@stanford.edu

CONTACT